Dr. Ash Tewari's Prostate Cancer Blog

Imaging as a biomarker for screening, active surveillance, and early risk stratification – Dr. Mark Emberton

Ash — Fri, 06 Apr 2012 16:12:01 +0000

Mark Emberton’s talk “Imaging as a biomarker for screening, active surveillance, and early risk stratification” from the International Prostate Cancer Symposium. Dates for the 2012 symposium to be announced soon. Read More

April 5 – Dr. Mani Menon speaks at the LeFrak Robotic Surgery Center

Ash — Wed, 04 Apr 2012 18:02:28 +0000

Should We Ignore Prostate Cancer? Mani Menon, MD Chairman, Department of Urology Director, Vattikuti Urology Institute Henry Ford Health System, Detroit, MI Thursday, April 5, 2012 12:00 – 1:00 PM Weill Cornell Medical College 1300 York Avenue Room A-950 All are welcome! RSVP and Inquiries should be directed to: rol2013 (at) med.cornell.edu About This Presentation [...]

Tracking the Rise of Robotic Surgery for Prostate Cancer

Ash — Sun, 18 Mar 2012 02:18:36 +0000

From the National Cancer Institute Bulletin Published August 9, 2011 By – Carmen Phillips In the 11 years since the Food and Drug Administration (FDA) approved the first robotic surgical system for conducting abdominal and pelvic surgeries, its use has skyrocketed. The da Vinci Surgical System is now used to perform as many as 4 [...]

International Prostate Cancer Symposium – Critiques on Screening – Peter Albertsen

Ash — Tue, 06 Mar 2012 22:03:39 +0000

Peter Albertsen details prostate cancer screening in the United States. Background literature: 1. Stamey, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. 2. Catalona et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. 3. Roobol et al. Interval cancers in prostate cancer screening comparing [...]

International Prostate Cancer Symposium – Robotic Prostate Cancer Surgery

Ash — Mon, 05 Mar 2012 22:55:59 +0000

Here is my talk from the International Prostate Cancer Symposium. I cover how I evaluate patients for robotic prostate cancer surgery including use of MRI and mapping biopsies. I review my outcomes and use of anatomic landmarks.